Gadofosveset trisodium

This classification denotes a gadolinium-chelate with the molecular formula C33H38N3O14P.Gd.3Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XM33Q67UVH, chemically known as gadolinate(3-), (((4r)-4-(bis((carboxy-kappao)methyl)amino-kappan)-6,9-bis((carboxy-kappao)methyl)-1-((4,4-diphenylcyclohexyl)oxy)-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-oic acid-kappan6,kappan9,kappao11) 1-oxidato(6-))-, trisodium but more generally known as gadofosveset trisodium, which bears U.S. National Institutes of Health Compound Identifier 158440. European Medicines Agency schedules Gadofosveset trisodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21051. Most nations schedule gadofosveset trisodium under HS 28469000 and SITC 52595. As of Q4 2014, GADOFOSVESET TRISODIUM remains the US FDA Preferred Term for this commodity. Gadofosveset trisodium bears US NLM identifiers UMLS ID C1433439 and NCI Concept Code C81057. SMILES: C1CCC(CC1)C2(CCC(CC2)OP(=O)([O-])OC[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])C3CCCCC3.O.[NA+].[NA+].[NA+].[GD+3].